Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rivers

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
BMJ Paediatrics Open|June 22, 2026
Association between perfluoroalkyl and polyfluoroalkyl substances and response to the COVID-19 vaccine in a paediatric prospective observational cohort in ArizonaJames Hollister, Cynthia Porter, Boqi Xiang, et al.
AIDS and Behavior|May 18, 2021
Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural StatesGregory Carter, Beth Meyerson, Patrick Rivers, et al.
Vaccine|December 15, 2021
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workersKaren Lutrick, Holly Groom, Ashley L Fowlkes, et al.
JAMA Health Forum|August 17, 2022
Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in ArizonaKatherine D Ellingson, Joe K Gerald, Xiaoxiao Sun, et al.
JMIR Research Protocols|May 31, 2021
COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research ProtocolKaren Lutrick, Katherine D Ellingson, Zoe Baccam, et al.
Vaccine|February 2, 2024
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort studyPatrick Rivers, Cynthia Porter, Lindsay B LeClair, et al.
Open Forum Infectious Diseases|September 4, 2023
Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5-11 Years in a Multisite Prospective Cohort Study, September 2021-September 2022Zoe L Lyski, Cynthia Porter, Jennifer L Uhrlaub, et al.
JAMA Network Open|February 24, 2025
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 YearsAnna R Yousaf, Josephine Mak, Lisa Gwynn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2024
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort StudyJames K Romine, Huashi Li, Melissa M Coughlin, et al.
MMWR. Morbidity and Mortality Weekly Report|December 30, 2021
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021Karen Lutrick, Patrick Rivers, Young M Yoo, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
BMJ Paediatrics Open|June 22, 2026
Association between perfluoroalkyl and polyfluoroalkyl substances and response to the COVID-19 vaccine in a paediatric prospective observational cohort in ArizonaJames Hollister, Cynthia Porter, Boqi Xiang, et al.
AIDS and Behavior|May 18, 2021
Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural StatesGregory Carter, Beth Meyerson, Patrick Rivers, et al.
Vaccine|December 15, 2021
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workersKaren Lutrick, Holly Groom, Ashley L Fowlkes, et al.
JAMA Health Forum|August 17, 2022
Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in ArizonaKatherine D Ellingson, Joe K Gerald, Xiaoxiao Sun, et al.
JMIR Research Protocols|May 31, 2021
COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research ProtocolKaren Lutrick, Katherine D Ellingson, Zoe Baccam, et al.
Vaccine|February 2, 2024
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort studyPatrick Rivers, Cynthia Porter, Lindsay B LeClair, et al.
Open Forum Infectious Diseases|September 4, 2023
Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5-11 Years in a Multisite Prospective Cohort Study, September 2021-September 2022Zoe L Lyski, Cynthia Porter, Jennifer L Uhrlaub, et al.
JAMA Network Open|February 24, 2025
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 YearsAnna R Yousaf, Josephine Mak, Lisa Gwynn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2024
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort StudyJames K Romine, Huashi Li, Melissa M Coughlin, et al.
MMWR. Morbidity and Mortality Weekly Report|December 30, 2021
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021Karen Lutrick, Patrick Rivers, Young M Yoo, et al.
Pageof 3